gold has been researched along with beta-Thalassemia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, TC; Chau, LK; Huang, TT; Kuo, PL; Ngo, LT; Tseng, YT; Wang, WK | 1 |
| Ding, F; Liu, W; Mao, L; Rao, H; Wang, X; Wang, Y; Zhao, Q; Zou, P | 1 |
| Borgatti, M; Breveglieri, G; D'Agata, R; Gambari, R; Spoto, G; Zanoli, LM | 1 |
| Franzen, S; Liu, Y | 1 |
4 other study(ies) available for gold and beta-Thalassemia
| Article | Year |
|---|---|
MutS protein-based fiber optic particle plasmon resonance biosensor for detecting single nucleotide polymorphisms.
Topics: beta-Thalassemia; Biosensing Techniques; DNA, Single-Stranded; Gold; Humans; Limit of Detection; Metal Nanoparticles; MutS Proteins; Optical Fibers; Point Mutation; Polymorphism, Single Nucleotide; Reference Standards; Surface Plasmon Resonance | 2021 |
A ratiometric fluorometric and colorimetric probe for the β-thalassemia drug deferiprone based on the use of gold nanoclusters and carbon dots.
Topics: beta-Thalassemia; Carbon; Colorimetry; Deferiprone; Fluorometry; Gold; Humans; Iron; Metal Nanoparticles; Quantum Dots | 2018 |
Direct detection of point mutations in nonamplified human genomic DNA.
Topics: beta-Thalassemia; DNA; Gold; Humans; Metal Nanoparticles; Point Mutation; Sensitivity and Specificity; Surface Plasmon Resonance; Surface Properties | 2011 |
Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles.
Topics: Alternative Splicing; beta-Thalassemia; Biotinylation; Cell Nucleus; Colloids; Endocytosis; Endosomes; Genetic Vectors; Gold; HeLa Cells; Humans; Lipids; Metal Nanoparticles; Oligonucleotides, Antisense; RNA, Messenger; Serum Albumin, Bovine; Sulfhydryl Compounds; Thionucleotides | 2008 |